Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cara D. Carey"'
Autor:
Zuqiang Liu, Xingxing Hao, Yi Zhang, Jiying Zhang, Cara D. Carey, Louis D. Falo, Walter J. Storkus, Zhaoyang You
Publikováno v:
OncoImmunology, Vol 6, Iss 6 (2017)
The progressive tumor microenvironment (TME) coordinately supports tumor cell expansion and metastasis, while it antagonizes the survival and (poly-)functionality of antitumor T effector cells. There remains a clear need to develop novel therapeutic
Externí odkaz:
https://doaj.org/article/35b8db487d9a45c1afff76d70f048341
Autor:
Xingxing Hao, Louis D Falo III, Guo Chen, Jiying Zhang, Cara D Carey, Walter J Storkus, Louis D Falo Jr, Zhaoyang You
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
BackgroundDespite the remarkable benefits associated with the interventional treatment of melanomas (and other solid cancers) with immune checkpoint and Braf inhibitors (Brafi), most patients ultimately progress on therapy. The presence of multifocal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::717fb02489225072ea8a033cd699c81f
http://europepmc.org/articles/PMC7789470
http://europepmc.org/articles/PMC7789470
Autor:
Li’an Williams, William F Hawse, Richard Cattley, Cara D Carey, Jiying Zhang, Louis D Falo, Adriana T Larregina, Tina L Sumpter
Publikováno v:
The Journal of Immunology. 206:23.05-23.05
Cutaneous mast cells (MCs) reside in close proximity to peripheral sensory nerve fibers and are susceptible to regulation by neuropeptides. The tachykinin family member, Neurokinin A (NKA) binds with highest affinity to the Neurokinin 2 Receptor, exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea587b1564600ef45238e415b16d0365
https://doi.org/10.4049/jimmunol.206.supp.23.05
https://doi.org/10.4049/jimmunol.206.supp.23.05
Autor:
Louis D Falo, Xingxing Hao, Guo Chen, Cara D Carey, Zuqiang Liu, David Bartlett, Walter J Storkus, Zhaoyang You
Publikováno v:
The Journal of Immunology. 206:57.25-57.25
Blockade of immune checkpoint PD1 in cancer patients results in remarkable therapeutic benefits. Revealing mechanisms underlying this revolutionary therapy is critical to identifying biomarkers for predicting responses to this treatment and developin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1c7c3613294567d725a96e6de19ec1c
https://doi.org/10.4049/jimmunol.206.supp.57.25
https://doi.org/10.4049/jimmunol.206.supp.57.25
Publikováno v:
Cancer Immunology Research. 8:A37-A37
Despite the remarkable treatment benefits associated with interventional checkpoint PD1 blockade in cancer, most patients ultimately progress on therapy. Revealing mechanisms underlying tumors responsive to PD1 blockade is critical to identifying bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19383b1bb842da782a8ecc5bdacae55a
https://doi.org/10.1158/2326-6074.tumimm19-a37
https://doi.org/10.1158/2326-6074.tumimm19-a37